Evaluation of Cardiac Burden in Patients With Sever Bronchial Asthma

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-01-17

Study Completion Date

2026-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Evaluation of cardiac burden in patients with sever bronchial asthma

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of Cardiac Biomarkers and Ventricular Function in Asthmatic Children

NCT05985720

Ventricular Dysfunction Asthma in Children

UNKNOWN

Presenteeism in Severe Asthma Treated by Biotherapyasthma

NCT04463589

Asthma

COMPLETED

Evaluation of the Frequency of Limitation of Activity in Patients With Persistent Asthma

NCT01078688

Persistent Asthma

COMPLETED

Cohort Analysis of Clinical and Biological Severe Childhood Asthma

NCT02114034

Severe Asthma

ACTIVE_NOT_RECRUITING

Predictors of Hospital-Based Care in Asthma

NCT00005484

Asthma Lung Diseases

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Bronchial asthma is chronic bronchial inflammation of variable intensity accompanied by recurrent reversible airflow obstruction and symptoms such as coughing, wheezing, shortness of breath, and chest tightness ,with a worldwide increase over the last several decades (1).

1. Sever asthma :means that asthma is uncontrolled despite adherence with maximal optimized therapy and treatment contributory factors or that worsens when high dose treatment is reduced.
2. Globally. over 260 million people had poorly controlled asthma highest rate on Australia.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Evaluation of Cardiac Burden in Patients With Sever Bronchial Asthma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ECHO in sever asthma patient

Evaluation of cardiac burden in patients with sever bronchial asthma

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients accepted to be involved in the study.
* Patients \>18 years old .

Exclusion Criteria

* severe bronchial asthma patients who have other comorbidities as (chronic chest disease as COPD,ILD, bronchiectasis , , diabetic ,hypertensive ,mechanical ventilated patients, tracheostomized patients, ……)
* patients \<18 years old . patients refuse to be involved in the study .

Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No